Carregant...
PCSK9: From Basic Science Discoveries to Clinical Trials
Unknown fifteen years ago, proprotein convertase subtilisin/kexin type 9 (PCSK9) is now common parlance amongst scientists and clinicians interested in prevention and treatment of atherosclerotic cardiovascular disease. What makes this story so special is not its recent discovery nor the fact that i...
Guardat en:
| Publicat a: | Circ Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5976255/ https://ncbi.nlm.nih.gov/pubmed/29748367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.118.311227 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|